Disease Info Card

Oligodendroglioma

Information about Oligodendroglioma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Oligodendroglioma

Most recent studies have shown that Oligodendroglioma shares some biological mechanisms with anaplastic-astrocytoma, anaplastic-oligodendroglioma, astrocytoma, brain-neoplasms, central-nervous-system-neoplasms, ependymoma, glioblastoma, glioblastoma-multiforme, glioma, malignant-glioma, malignant-neoplasms, malignant-paraganglionic-neoplasm, medulloblastoma, meningioma, mixed-oligodendroglioma-astrocytoma, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, nervousness, neurilemmoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Oligodendroglioma, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Cycle, Cell Death, Cell Differentiation, Cell Division, Cell Growth, Cell Migration, Cell Proliferation, Dedifferentiation, Dna Repair, Immune Response, Interphase, Localization, Methylation, Mitosis, Oncogenesis, Pathogenesis, Secretion, Transport

Quite a number of genes have been found to play important roles in Oligodendroglioma, such as CDKN2A, CSF2, EGFR, ENO2, GFAP, IDH1, IDH2, LAMC2, MBP, MGMT, MID1, OLIG2, PCNA, PTEN, SYP, TP53, VEGFA, VIM. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.